104 related articles for article (PubMed ID: 16446310)
1. A role for Brca1 in chromosome end maintenance.
McPherson JP; Hande MP; Poonepalli A; Lemmers B; Zablocki E; Migon E; Shehabeldin A; Porras A; Karaskova J; Vukovic B; Squire J; Hakem R
Hum Mol Genet; 2006 Mar; 15(6):831-8. PubMed ID: 16446310
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal aberrations involving telomeres in BRCA1 deficient human and mouse cell lines.
Al-Wahiby S; Slijepcevic P
Cytogenet Genome Res; 2005; 109(4):491-6. PubMed ID: 15905643
[TBL] [Abstract][Full Text] [Related]
3. Mammary tumor formation in p53- and BRCA1-deficient mice.
Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
[TBL] [Abstract][Full Text] [Related]
4. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
Fedier A; Steiner RA; Schwarz VA; Lenherr L; Haller U; Fink D
Int J Oncol; 2003 May; 22(5):1169-73. PubMed ID: 12684687
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells.
Cabuy E; Newton C; Slijepcevic P
Cytogenet Genome Res; 2008; 122(3-4):336-42. PubMed ID: 19188703
[TBL] [Abstract][Full Text] [Related]
6. Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice.
Sgura A; De Amicis A; Stronati L; Cinelli S; Pacchierotti F; Tanzarella C
Environ Mol Mutagen; 2008 Jul; 49(6):467-75. PubMed ID: 18481314
[TBL] [Abstract][Full Text] [Related]
7. Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells.
Pantic M; Zimmermann S; El Daly H; Opitz OG; Popp S; Boukamp P; Martens UM
Oncogene; 2006 Jul; 25(32):4413-20. PubMed ID: 16547498
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
[TBL] [Abstract][Full Text] [Related]
9. Telomere shortening is associated with malformation in p53-deficient mice after irradiation during specific stages of development.
Bekaert S; Derradji H; De Meyer T; Michaux A; Buset J; Neefs M; Mergeay M; Jacquet P; Van Oostveldt P; Baatout S
DNA Repair (Amst); 2005 Aug; 4(9):1028-37. PubMed ID: 15990362
[TBL] [Abstract][Full Text] [Related]
10. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
[TBL] [Abstract][Full Text] [Related]
11. A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
Xing D; Orsulic S
Cancer Res; 2006 Sep; 66(18):8949-53. PubMed ID: 16982732
[TBL] [Abstract][Full Text] [Related]
12. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.
Hohenstein P; Kielman MF; Breukel C; Bennett LM; Wiseman R; Krimpenfort P; Cornelisse C; van Ommen GJ; Devilee P; Fodde R
Oncogene; 2001 May; 20(20):2544-50. PubMed ID: 11420664
[TBL] [Abstract][Full Text] [Related]
13. The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.
Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE
Carcinogenesis; 2007 Oct; 28(10):2131-8. PubMed ID: 17615258
[TBL] [Abstract][Full Text] [Related]
14. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
Jeng YM; Cai-Ng S; Li A; Furuta S; Chew H; Chen PL; Lee EY; Lee WH
Oncogene; 2007 Sep; 26(42):6160-6. PubMed ID: 17420720
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
[TBL] [Abstract][Full Text] [Related]
16. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA; Glickman J; Horner J; Depinho RA
Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of Parp1 accelerates Brca1-associated centrosome amplification, telomere shortening, genetic instability, apoptosis, and embryonic lethality.
Wang X; Liu L; Montagna C; Ried T; Deng CX
Cell Death Differ; 2007 May; 14(5):924-31. PubMed ID: 17318223
[TBL] [Abstract][Full Text] [Related]
18. Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.
Bachelier R; Xu X; Wang X; Li W; Naramura M; Gu H; Deng CX
Oncogene; 2003 Jan; 22(4):528-37. PubMed ID: 12555066
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin.
Pageau GJ; Hall LL; Lawrence JB
J Cell Biochem; 2007 Mar; 100(4):835-50. PubMed ID: 17146760
[TBL] [Abstract][Full Text] [Related]
20. Telomere uncapping, chromosomes, and carcinomas.
Batista LF; Artandi SE
Cancer Cell; 2009 Jun; 15(6):455-7. PubMed ID: 19477422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
